CN Patent

CN117843619A — 囊性纤维化跨膜传导调控剂的调节剂、药物组合物、治疗方法和制备所述调节剂的方法

Assigned to Vertex Pharmaceuticals Inc · Expires 2024-04-09 · 2y expired

What this patent protects

本文公开式(I)化合物，其药学上可接受的盐、上述任一者的氘化衍生物和上述任一者的代谢物。本文还公开包含上述各项的药物组合物、使用上述各项来治疗囊性纤维化的方法和制备上述各项的方法。本文还公开化合物1及其盐和溶剂合物的固态形式。

USPTO Abstract

本文公开式(I)化合物，其药学上可接受的盐、上述任一者的氘化衍生物和上述任一者的代谢物。本文还公开包含上述各项的药物组合物、使用上述各项来治疗囊性纤维化的方法和制备上述各项的方法。本文还公开化合物1及其盐和溶剂合物的固态形式。

Drugs covered by this patent

Patent Metadata

Patent number: CN117843619A
Jurisdiction: CN
Classification: —
Expires: 2024-04-09
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.